72 Views | 35 Downloads
Ruth Sapir-Pichhadze, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, 5252 boul de Maisonneuve, Office 3E.13, Montréal, QC H4A 3S5, Canada. Email: ruth.sapir-pichhadze@mcgill.ca
Study conception and design: HM, KO, RSP Acquisition of data: RSP, BF Analysis and interpretation of data: HM, KO, WZ, WK, AB, JL, YY, RSP Drafting of manuscript: HM, RSP Critical revision: HM, KO, WZ, WK, AB, JL, YY, BF, PK, HMG, FC, RSP
Analyses reported in this article were made possible thanks to Compute Canada Resources for Research Groups 2020: 3021 (RS-P, cna-921–02). We are grateful to Rene Duquesnoy and Marilyn Marrari for their support with HLAMatchmaker and the HLA Epitope Registry. We are grateful to Gilbert J. Burckart, Pharm.D, members of the Genome Canada Transplant Consortium. This work was supported by Genome Canada Large Scale Applied Research Program Award “Precision Medicine CanPREVENT AMR” (273AMR) funded by Genome Quebec, Canada; Genome British Columbia, Canada; Genome Alberta, Canada; and Canadian Institutes of Health Research (CIHR), Canada. RS-P is also supported by a Fonds de recherche du Quebec—Santé chercheur boursier clinician award (grant no. 254386).
All the authors declared no competing interests.
© 2021 International Society of Nephrology. Published by Elsevier Inc.